Cancer cachexia: Are we ready to take a step forward?
Mené au Japon sur 174 patients atteints d'un cancer du poumon non à petites cellules de stade III/IV et non résécable, cet essai randomisé évalue l'efficacité et la toxicité de l'anamoréline pour traiter une cachexie liée à la maladie
The field of cancer cachexia at both the preclinical and clinical levels will benefit from the further investigation and refinement of its mechanisms and further study of potential agents to define the best treatment outcomes for patients. In the meantime, the availability of anamorelin, a promising agent in the clinic would be extremely valuable to move that research forward.
Cancer , éditorial, 2016